Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin 1 (XPO1) antagonist selinexor (KPT-330) in patients (pts) with platinum resistant/refractory ovarian cancer (OVCA) Meeting Abstract
| Authors: | Martignetti, J.; Razak, A. R. A.; Chen, Y.; Gabrail, N. Y.; Gerecitano, J. F.; Camacho, C.; Pereira, E.; Evans, B.; Dottino, P.; McCauley, D.; Shacham, S.; Rashal, T.; Saint-Martin, J.; Shacham, E.; Vincent, D.; Kauffman, M.; Mirza, M. R.; Mau-Sorensen, M. |
| Abstract Title: | Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin 1 (XPO1) antagonist selinexor (KPT-330) in patients (pts) with platinum resistant/refractory ovarian cancer (OVCA) |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Start Page: | iv310 |
| Language: | English |
| ACCESSION: | WOS:000346901000263 |
| DOI: | 10.1093/annonc/mdu338.14 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 888P -- Source: Wos |
